Natural killer cell engineering for cellular therapy of cancer - Wikidata - awgldk - TriplyDB

Natural killer cell engineering for cellular therapy of cancer

Natural killer cell engineering for cellular therapy of cancer

http://www.wikidata.org/entity/Q35556865

about

Innate immune cells in liver inflammation "Adherent" versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential.Enhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors.Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumors Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol Hematopoietic stem cells for cancer immunotherapy Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD.Immunotherapeutic applications of IL-15.In Vitro Generation of Human NK Cells Expressing Chimeric Antigen Receptor Through Differentiation of Gene-Modified Hematopoietic Stem Cells.Natural Killer Cell Functional Activity After 4-1BB Costimulation.Surface engineering for lymphocyte programming.Natural killer cell therapy for cancer: delivering on a promise.Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients.Cellular therapy for cancer: let there be light.

P2860

Q26859951-78116C88-5F31-4FA1-BCF5-573C838E319C Q28081338-EC74B40B-88F6-4AE8-8844-703A61221D1C Q35634680-A2E586A6-7F68-4345-AB2E-E22961AD895E Q36177023-14EE3B7E-8585-4051-955B-903EB6EEF5A2 Q36398704-806BEF95-E904-44A1-BE33-68D3669BC2DF Q36850695-FA42BD30-F2AD-4957-8C44-4CCEA1BA6B6B Q37512048-8FD1717C-1453-43E5-A525-EC5CBC58CE17 Q37993738-D4261511-CD2F-4619-A8D0-6911BA86F628 Q38050510-22CA7145-0442-4423-90BA-8488BC19C34B Q38771094-56CB4D50-8C43-403F-B174-21A9CCD28356 Q38927515-FC1291F6-DD66-4786-86A7-93F9658BC28E Q40214162-63699AFD-4DA4-4133-9EBE-648768D79E49 Q44360875-13E46EAF-390E-4895-AB61-760CF9E4B2A0 Q44823723-A5884E5A-EA02-4E05-9B78-B5694E2013DD Q45875669-A9FCC796-FFEC-4C44-BFED-856259733526

P2860

Natural killer cell engineering for cellular therapy of cancer

http://www.wikidata.org/entity/Q35556865

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Natural killer cell engineering for cellular therapy of cancer

@ast

Natural killer cell engineering for cellular therapy of cancer

@en

type

label

Natural killer cell engineering for cellular therapy of cancer

@ast

Natural killer cell engineering for cellular therapy of cancer

@en

prefLabel

Natural killer cell engineering for cellular therapy of cancer

@ast

Natural killer cell engineering for cellular therapy of cancer

@en

P1433

Q35556865-58F6F11A-78DD-4601-9CF4-8C64F8FB2C9C

P1476

Q35556865-78AC9EB3-CB8A-4C94-8BD4-37C0192549AA

P2093

Q35556865-03229A9C-3B5F-4FD0-817B-AE9F128249EC

Q35556865-91409F74-C905-41E4-BCD4-DFA3728F48A4

P2860

Q35556865-0D39835A-580B-4E30-80E8-99A6A9BEA9D7

Q35556865-12198073-033C-4D51-86F7-ED575916DF9D

Q35556865-140493D3-184B-4453-A9C1-A1AA5578111A

Q35556865-143AFFC0-3C05-46BA-A81F-9BACE3047158

Q35556865-1533B1F1-532C-4B2C-963F-DA3282A5DCB2

Q35556865-17144816-95C1-42FD-BD24-42624A3892C5

Q35556865-226AF885-E682-4B01-97DE-1976A4D9EEBF

Q35556865-2536785C-C490-4359-8726-A9A6BF5F2901

Q35556865-26596458-21F2-4E45-A061-2E5904FE73EB

Q35556865-28266238-9575-451B-8AE7-DD041CCB92C5

P304

Q35556865-580648B6-9EFA-4F1D-AE8F-871D074D98A3

P31

Q35556865-BAE32026-32E6-4EA4-BA0E-91EC057245A2

P356

Q35556865-0E8DB59A-ABDE-4755-A091-F3F3E991DE45

P433

Q35556865-FC82386B-3216-4019-A294-7C0E4B7DEA46

P478

Q35556865-9F10EEFD-8501-49C2-8B73-96523AF09453

P577

Q35556865-94769E4C-5EE6-4B63-9D76-9E2D9E44DA68

P5875

Q35556865-7CF790AF-9929-4798-AD20-5FD372548C8A

P698

Q35556865-996B49D1-A4E1-4116-95DB-A9E34D22B3D6

P932

Q35556865-62B08678-7580-4FAC-A3F8-174C1743737E

P356

J.1399-0039.2011.01796.X

P1433

Tissue Antigens

P1476

Natural killer cell engineering for cellular therapy of cancer

@en

P2093

D Campana

http://www.w3.org/2001/XMLSchema#string

D R Shook

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells

Innate or adaptive immunity? The example of natural killer cells

NK cell recognition

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Cytotoxicity of activated natural killer cells against pediatric solid tumors.

NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.

Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells

Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation

P304

409-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-0039.2011.01796.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51793300

http://www.w3.org/2001/XMLSchema#string

P698

22077621

http://www.w3.org/2001/XMLSchema#string

P932

3218564

http://www.w3.org/2001/XMLSchema#string